Basic Information
ID: ALA3090145
Type: Functional
Description: Antiviral activity against Western equine encephalomyelitis virus infected in human BE(2)-C cells assessed as inhibition of viral RNA replication after 18 to 20 hrs by luciferase reporter gene assay
Organism: Western equine encephalitis virus
Activity Charts
Bioactivity
Activity Types for Assay ALA3090145
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 244.21 | -3.01 | -3.01 |
| 465.55 | 4.65 | 4.65 |
| 487.00 | 4.91 | 4.91 |
| 414.94 | 3.06 | 3.06 |
| 390.49 | 2.78 | 2.78 |
| 466.59 | 4.30 | 4.30 |
| 502.57 | 4.57 | 4.57 |
| 519.02 | 5.09 | 5.09 |
| 519.02 | 5.09 | 5.09 |
| 502.02 | 4.34 | 4.34 |
| 468.96 | 3.94 | 3.94 |
| 542.12 | 6.68 | 6.68 |
| 480.01 | 4.18 | 4.18 |
| 423.94 | 4.28 | 4.28 |
| 449.98 | 4.82 | 4.82 |
| 465.98 | 4.05 | 4.05 |
| 500.04 | 5.85 | 5.85 |
| 510.59 | 5.11 | 5.11 |
| 490.61 | 5.07 | 5.07 |
| 495.62 | 5.21 | 5.21 |
| 417.51 | 3.81 | 3.81 |
| 433.55 | 3.80 | 3.80 |
| 431.58 | 4.81 | 4.81 |
| 465.60 | 5.20 | 5.20 |
| 466.59 | 4.60 | 4.60 |
| 533.59 | 6.22 | 6.22 |
| 450.97 | 3.80 | 3.80 |
| 451.96 | 3.19 | 3.19 |
| 502.02 | 4.34 | 4.34 |
| 486.02 | 5.51 | 5.51 |
| 500.04 | 6.07 | 6.07 |
| 487.00 | 4.91 | 4.91 |
| 501.03 | 5.47 | 5.47 |
| 501.03 | 5.47 | 5.47 |
| 479.02 | 3.97 | 3.97 |
| 507.08 | 4.65 | 4.65 |
| 490.01 | 4.25 | 4.25 |
| 490.01 | 4.25 | 4.25 |
| 501.03 | 4.95 | 4.95 |
| 501.03 | 4.95 | 4.95 |
| 501.03 | 4.95 | 4.95 |
| 515.06 | 5.34 | 5.34 |
| 515.06 | 5.51 | 5.51 |
| 529.08 | 5.73 | 5.73 |
| 515.06 | 5.29 | 5.29 |
| 529.04 | 4.88 | 4.88 |
| 490.01 | 4.21 | 4.21 |
| 530.07 | 5.56 | 5.56 |
| 518.03 | 5.69 | 5.69 |
| 530.07 | 5.56 | 5.56 |
| 534.49 | 6.21 | 6.21 |